新検索ページはこちら
ログイン
お問い合わせ
（旧版）ED診療ガイドライン 2012年版
書誌情報
4
EDのリスクファクター
| 参考文献 |
| 1） | Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54- 61. （レベルIVb） |
| 2） | 丸井英二．わが国におけるEDの疫学とリスクファクター．医学のあゆみ2002; 201: 397- 400 （レベルIVb） |
| 3） | Masumori N, Tsukamoto T, Kumamoto Y, Panser LA, Rhodes T, Girman CJ, Lieber MM, Jacobsen SJ. Decline of sexual function with age in Japanese men compared with American men-results of two community-based studies. Urology 1999; 54: 335- 345（レベルIVb） |
| 4） | Marumo K, Nakashima J, Murai M. Age-related prevalence of erectile dysfunction in Japan: assessment by the International Index of Erectile Function. Int J Urol 2001; 8: 53- 59（レベルIVb） |
| 5） | Sasayama S, Ishii N, Ishikura F, Kamijima G, Ogawa S, Kanmatsuse K, Kimoto Y, Sakuma I, Nonogi H, Matsumori A, Yamamoto Y. Men’s Health Study - epidemiology of erectile dysfunction and cardiovascular disease. Circ J 2003; 67: 656- 659（レベルIVb） |
| 6） | Terai A, Ichioka K, Matsui Y, Yoshimura K. Association of lower urinary tract symptoms with erectile dysfunction in Japanese men. Urology 2004; 64: 132-136（レベルIVb） |
| 7） | Akkus E, Carrier S, Baba K, Hsu G-L, Padma-Nathan H, Nunes L, Lue TF. Structural alterations in the tunica albuginea of the penis: impact of Peyronie’s disease, ageing and impotence. Br J Urol 1997; 79: 47- 53（レベルIVb） |
| 8） | 岩本晃明，柳瀬敏彦，高栄哲，堀江均，馬場克幸，並木幹夫，名和田新．日本人成人男子の 総テストステロン，遊離テストステロンの基準値の設定．日泌尿会誌2004; 95: 751- 760. （レベルIVb） |
| 9） | Seftel AD. Erectile dysfunction in the elderly: epidemiology, etiology and approaches to treatment. J Urol 2003; 169: 1999- 2007（レベルI） |
| 10） | McVary KT, Carrier S, Wessells H and the Subcommittee on Smoking and Erectile Dysfunction Socioeconomic Committee, Sexual Medicine Society of North America. Smoking and erectile dysfunction: evidence based analysis. J Urol 2001; 166: 1624-1632（レベルI） |
| 11） | Rosen MP, Greenfield AJ, Walker TG, Grant P, Dubrow J, Bettmann MA, Fried LE, Goldstein I. Cigarette smoking: an independent risk factor for atherosclerosis in the hypogastric-cavernous arterial bed of men with arteriogenic impotence. J Urol 1991; 145: 759- 763（レベルIVb） |
| 12） | Hirshkowitz M, Karacan I, Howell JW, Arcasoy MO, Williams RI. Nocturnal penile tumescence in cigarette smokers with erectile dysfunction. Urology 1992; 39: 101-107（レベルIVb） |
| 13） | Millett C, Wen LM, Rissel C, Smith A, Richters J, Grulich A, de Visser R. Smoking and erectile dysfunction: findings from a representative sample of Australian men. Tob Control 2006; 15: 136 -139（レベルIVb） |
| 14） | Lam TH, Abdullah ASM, Ho LM, Yip AWC, Fan S. Smoking and sexual dysfunction in Chinese males: findings from men’s health survey. Int J Impot Res 2006; 18: 364- 369（レベルIVb） |
| 15） | Polsky JY, Aronson KJ, Heaton JPW, Adams MA. Smoking and other lifestyle factors in relation to erectile dysfunction. BJU Int 2005; 96: 1355-1359（レベルIVb） |
| 16） | Nicolosi A, Glasser DB, Moreira ED, Villa M. Prevalence of erectile dysfunction and associated factors among men without concomitant diseases: a population study. Int J Impot Res 2003; 15: 253-257. （レベルIVb） |
| 17） | Feldman HA, Johannes CB, Derby CA, Kleinman KP, Mohr BA, Araujo AB, McKinlay JB. Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts Male Aging Study. Prev Med 2000; 30: 328- 338（レベルIVa） |
| 18） | Kupelian V, Link CL, McKinlay JB. Association between smoking, passive smoking, and erectile dysfunction: results from the Boston Area Community Health（BACH） Survey. Eur Urol 2007; 52: 416- 422（レベルIVb） |
| 19） | Guay AT, Perez JB, Heatley GJ. Cessation of smoking rapidly decreases erectile dysfunction. Endocr Pract 1998; 4: 23- 26（レベルIVb） |
| 20） | Derby CA, Mohr BA, Goldstein I, Feldman HA, Johannes CB, McKinlay JB. Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk? Urology 2000; 56: 302-306（レベルIVa） |
| 21） | Giuliano FA, Leriche A, Jaudinot EO, de Gendre AS. Prevalence of erectile dysfunction among 7689 patients with diabetes or hypertension, or both. Urology 2004; 64: 1196-1201（レベルIVb） |
| 22） | Aranda P, Ruilope LM, Calvo C, Luque M, Coca A, Gil De Miguel Á for the Sildenafil Study Group. Erectile dysfunction in essential arterial hypertension and effects of sildenafil: results of a Spanish national study. Am J Hypertens 2004; 17: 139-145（レベルIVb） |
| 23） | Burchardt M, Burchardt T, Baer L, Kiss AJ, Pawar RV, Shabsigh A, de la Taille A, Hayek OR, Shabsigh R. Hypertension is associated with severe erectile dysfunction. J Urol 2000; 164: 1188-1191（レベルIVb） |
| 24） | Sun P, Swindle R. Are men with erectile dysfunction more likely to have hypertension than men without erectile dysfunction? A naturalistic national cohort study. J Urol 2005; 174: 244- 248（レベルIVa） |
| 25） | Blumentals WA, Brown RR, Gomez-Caminero A. Antihypertensive treatment and erectile dysfunction in a cohort of type II diabetes patients. Int J Impot Res 2003; 15: 314- 317（レベルIVa） |
| 26） | Johannes CB, Araujo AB, Feldman HA, Derby CA, Kleinman KP, McKinlay JB. Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts Male Aging Study. J Urol 2000; 163: 460- 463（レベルIVa） |
| 27） | Vlachopoulos C, Aznaouridis K, Ioakeimidis N, Rokkas K, Tsekoura D, Vasiliadou C, Stefanadi E, Askitis A, Stefanadis C. Arterial function and intima-media thickness in hypertensive patients with erectile dysfunction. J Hypertens 2008; 26: 1829-1836（レベルIVb） |
| 28） | Sairam K, Kulinskaya E, Boustead GB, Hanbury DC, McNicholas TA. Prevalence of undiagnosed diabetes mellitus in male erectile dysfunction. BJU Int 2001; 88: 68- 71（レベルIVb） |
| 29） | McCulloch DK, Campbell IW, Wu FC, Prescott RJ, Clarke BF. The prevalence of diabetic impotence. Diabetologia 1980; 18: 279- 283（レベルIVb） |
| 30） | De Berardis G, Franciosi M, Belfiglio M, Di Nardo B, Greenfield S, Kaplan SH, Pellegrini F, Sacco M, Tognoni G, Valentini M, Nicolucci A for the Quality of Care and Outcomes in Type 2 Diabetes （QuED）Study Group. Erectile dysfunction and quality of life in type 2 diabetic patients: a serious problem too often overlooked. Diabetes Care 2002; 25: 284- 291（レベルIVb） |
| 31） | Bacon CG, Hu FB, Giovannucci E, Glasser DB, Mittleman MA, Rimm EB. Association of type and duration of diabetes with erectile dysfunction in a large cohort of men. Diabetes Care 2002; 25: 1458- 1463（レベルIVa） |
| 32） | Fedele D, Coscelli C, Santeusanio F, Bortolotti A, Chatenoud L, Colli E, Landoni M, Parazzini F on behalf of Gruppo Italiano Studio Deficit Erettile nei Diabetici. Erectile dysfunction in diabetic subjects in Italy. Diabetes Care 1998; 21: 1973-1977（レベルIVb） |
| 33） | Siu SC, Lo SK, Wong KW, Ip KM, Wong YS. Prevalence of and risk factors for erectile dysfunction in Hong Kong diabetic patients. Diabet Med 2001; 18: 732- 738（レベルIVb） |
| 34） | Cho NH, Ahn CW, Park JY, Ahn TY, Lee HW, Park TS, Kim IJ, Pomerantz K, Park C, Kimm KC, Choi DS. Prevalence of erectile dysfunction in Korean men with Type 2 diabetes mellitus. Diabet Med 2006; 23: 198- 203（レベルIVb） |
| 35） | Malavige LS, Jayaratne SD, Kathriarachchi ST, Sivayogan S, Fernando DJ, Levy JC. Erectile dysfunction among men with diabetes is strongly associated with premature ejaculation and reduced libido. J Sex Med 2008; 5: 2125- 2134（レベルIVb） |
| 36） | El-Sakka AI, Tayeb KA. Erectile dysfunction risk factors in noninsulin dependent diabetic Saudi patients. J Urol 2003; 169: 1043-1047（レベルIVb） |
| 37） | 清野弘明，山崎俊朗，熱海真希子，山口日吉，三崎麻子，北川昌之，武藤元，菊池宏明，阿部 隆三．糖尿病患者のErectile Dysfunction の頻度とクエン酸シルデナフィルの効果．内分泌糖 尿病2002; 15: 520- 524（レベルIVb） |
| 38） | Naya Y, Mizutani Y, Ochiai A, Soh J, Kawauchi A, Fujito A, Nakamura N, Ono T, Iwamoto N, Aoki T, Marumo K, Murai M, Miki T. Preliminary report of association of chronic diseases and erectile dysfunction in middle-aged men in Japan. Urology 2003; 62: 532- 536（レベルIVa） |
| 39） | Yamasaki H, Ogawa K, Sasaki H, Nakao T, Wakasaki H, Matsumoto E, Furuta H, Nishi M, Ueda K, Iwo K, Nanjo K. Prevalence and risk factors of erectile dysfunction in Japanese men with type 2 diabetes. Diabetes Res Clin Pract 2004; 66（Suppl 1）: S173-S177（レベルIVb） |
| 40） | Sasaki H, Yamasaki H, Ogawa K, Nanjo K, Kawamori R, Iwamoto Y, Katayama S, Shirai M. Prevalence and risk factors for erectile dysfunction in Japanese diabetics. Diabetes Res Clin Pract 2005; 70: 81 - 89（レベルIVb） |
| 41） | Rhoden EL, Ribeiro EP, Riedner CE, Teloken C, Souto CAV. Glycosylated haemoglobin levels and the severity of erectile function in diabetic men. BJU Int 2005; 95: 615- 617（レベルIVb） |
| 42） | 高橋良当，井上幸子，平田幸正．糖尿病性インポテンス症例の臨床像- 非インポテンス群と の比較検討- ．糖尿病1985; 28: 53- 60（レベルIVb） |
| 43） | Malavige LS, Levy JC. Erectile dysfunction in diabetes mellitus. J Sex Med 2009; 6: 1232-1247. （レベルI） |
| 44） | Corona G, Mannucci E, Petrone L, Ricca V, Balercia G, Mansani R, Chiarini V, Giommi R, Forti G, Maggi M. Association of hypogonadism and type II diabetes in men attending an outpatient erectile dysfunction clinic. Int J Impot Res 2006; 18: 190-197（レベルIVb） |
| 45） | Penson DF, Latini DM, Lubeck DP, Wallace KL, Henning JM, Lue TF. Do impotent men with diabetes have more severe erectile dysfunction and worse quality of life than the general population of impotent patients? Results from the Exploratory Comprehensive Evaluation of Erectile Dysfunction（ExCEED） database. Diabetes Care 2003; 26: 1093-1099（レベルIII） |
| 46） | Costa C, Soares R, Castela Â, Adães S, Hastert V, Vendeira P, Virag R. Increased endothelial apoptotic cell density in human diabetic erectile tissue-comparison with clinical data. J Sex Med 2009; 6: 826- 835（レベルIVb） |
| 47） | Gazzaruso C, Giordanetti S, De Amici E, Bertone G, Falcone C, Geroldi D, Fratino P, Solerte SB, Garzaniti A. Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients. Circulation 2004; 110: 22- 26（レベルIVb） |
| 48） | Gazzaruso C, Solerte SB, Pujia A, Coppola A, Vezzoli M, Salvucci F, Valenti C, Giustina A, Garzaniti A. Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease: a potential protective role for statins and 5-phosphodiesterase inhibitors. J Am Coll Cardiol 2008; 51: 2040- 2044（レベルIVa） |
| 49） | Vickers MA, Satyanarayana R. Phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction in patients with diabetes mellitus. Int J Impot Res 2002; 14: 466- 471（レベルI） |
| 50） | Ng KK, Lim HCP, Ng FC, Li MK, Consigliere D, Chia SJ. The use of sildenafil in patients with erectile dysfunction in relation to diabetes mellitus-a study of 1,511 patients. Singapore Med J 2002; 43: 387- 390（レベルIII） |
| 51） | Park K, Ku JH, Kim SW, Paick J-S. Risk factors in predicting a poor response to sildenafil citrate in elderly men with erectile dysfunction. BJU Int 2005; 95: 366- 370（レベルIII） |
| 52） | Fonseca V, Seftel A, Denne J, Fredlund P. Impact of diabetes mellitus on the severity of erectile dysfunction and response to treatment: analysis of data from tadalafil clinical trials. Diabetologia 2004; 47: 1914-1923（レベルI） |
| 53） | Seftel AD, Sun P, Swindle R. The prevalence of hypertension, hyperlipidemia, diabetes mellitus and depression in men with erectile dysfunction. J Urol 2004; 171: 2341-2345（レベルIVb） |
| 54） | Wei M, Macera CA, Davis DR, Hornung CA, Nankin HR, Blair SN. Total cholesterol and high density lipoprotein cholesterol as important predictors of erectile dysfunction. Am J Epidemiol 1994; 140: 930- 937（レベルIVa） |
| 55） | Hall SA, Kupelian V, Rosen RC, Travison TG, Link CL, Miner MM, Ganz P, McKinlay JB. Is hyperlipidemia or its treatment associated with erectile dysfunction?: results from the Boston Area Community Health（BACH）Survey. J Sex Med 2009; 6: 1402-1413（レベルIVb） |
| 56） | Ahn TY, Park JK, Lee SW, Hong JH, Park NC, Kim JJ, Park K, Park H, Hyun JS. Prevalence and risk factors for erectile dysfunction in Korean men: results of an epidemiological study. J Sex Med 2007; 4: 1269-1276（レベルIVb） |
| 57） | Miner M, Billups KL. Erectile dysfunction and dyslipidemia: relevance and role of phosphodiesterase type-5 inihibitors and statins. J Sex Med 2008; 5: 1066-1078（総説） |
| 58） | Bacon CG, Mittleman MA, Kawachi I, Giovannucci E, Glasser DB, Rimm EB. A prospective study of risk factors for erectile dysfunction. J Urol 2006; 176: 217- 221（レベルIVa） |
| 59） | Travison TG, Shabsigh R, Araujo AB, Kupelian V, O’Donnell AB, McKinlay JB. The natural progression and remission of erectile dysfunction: results from the Massachusetts Male Aging Study. J Urol 2007; 177: 241-246（レベルIVa） |
| 60） | Cheng JYW, Ng EML, Ko JSN, Chen RYL. Physical activity and erectile dysfunction: meta-analysis of population-based studies. Int J Impot Res 2007; 19: 245- 252（総説） |
| 61） | Sommer F, Goldstein I, Korda JB. Bicycle riding and erectile dysfunction: a review. J Sex Med 2010; 7: 2346- 2358（総説） |
| 62） | Gupta BP, Murad MH, Clifton MM, Prokop L, Nehra A, Kopecky SL. The effect of lifestyle modification and cardiovascular risk factor reduction on erectile dysfunction: a systematic review and meta-analysis. Arch Intern Med 2011; 171: 1797-1803（レベルI） |
| 63） | Khoo J, Piantadosi C, Worthley S, Wittert GA. Effects of a low-energy diet on sexual function and lower urinary tract symptoms in obese men. Int J Obes 2010; 34: 1396-1403（レベルII） |
| 64） | Maio G, Saraeb S, Marchiori A. Physical activity and PDE5 inhibitors in the treatment of erectile dysfunction: results of a randomized controlled study. J Sex Med 2010; 7: 2201-2208（レベルII） |
| 65） | Thase ME, Reynolds CF III, Jennings JR, Frank E, Howell JR, Houck PR, Berman S, Kupfer DJ. Nocturnal penile tumescence is diminished in depressed men. Biol Psychiatry 1988; 24: 33-46（レベルIVa） |
| 66） | Steiger A, Holsboef F, Benkert O. Studies of nocturnal penile tumescence and sleep electroencephalogram in patients with major depression and in normal controls. Acta Psychiatr Scand 1993; 87: 358- 363（レベルIVa） |
| 67） | Araujo AB, Durante R, Feldman HA, Goldstein I, McKinlay JB. The relationship between depressive symptoms and male erectile dysfunction: cross-sectional results from the Massachusetts Male Aging Study. Psychosom Med 1998; 60: 458- 465（レベルIVb） |
| 68） | Sugimori H, Yoshida K, Tanaka T, Baba K, Nishida T, Nakazawa R, Iwamoto T. Relationships between erectile dysfunction, depression and anxiety in Japanese subjects. J Sex Med 2005; 2: 390- 396（レベルIVb） |
| 69） | Shiri R, Koskimäki J, Tammela TLJ, Häkkinen J, Auvinen A, Hakama M. Bidirectional relationship between depression and erectile dysfunction. J Urol 2007; 177: 669- 673（レベルIVa） |
| 70） | Shabsigh R, Klein LT, Seidman S, Kaplan SA, Lehrhoff BJ, Ritter JS. Increased incidence of depressive symptoms in men with erectile dysfunction. Urology 1998; 52: 848- 852（レベルIVb） |
| 71） | Goldstein I. The mutually reinforcing triad of depressive symptoms, cardiovascular disease, and erectile dysfunction. Am J Cardiol 2000; 86（Suppl）: 41F -45F（総説） |
| 72） | Seidman SN, Roose SP, Menza MA, Shabsigh R, Rosen RC. Treatment of erectile dysfunction in men with depressive symptoms: results of a placebo-controlled trial with sildenafil citrate. Am J Psychiatry 2001; 158: 1623-1630（レベルII） |
| 73） | Rosen R, Shabsigh R, Berber M, Assalian P, Menza M, Rodriguez-Vela L, Porto R, Bangerter K, Seger M, Montorsi F, the Vardenafil Study Site Investigators. Efficacy and tolerability of vardenafil in men with mild depression and erectile dysfunction: the Depression-Related Improvement With Vardenafil for Erectile Response Study. Am J Psychiatry 2006; 163: 79- 87（レベルII） |
| 74） | Lewis RW, Sadovsky R, Eardley I, O’Leary M, Seftel A, Wang WC, Shen W, Walker DJ, Wong DG, Ahuja S. The efficacy of tadalafil in clinical populations. J Sex Med 2005; 2: 517- 531（レベルII） |
| 75） | 日本排尿機能学会 男性下部尿路症状診療ガイドライン作成委員会編．男性下部尿路症状診 療ガイドライン．ブラックウェルパブリッシング，2008（ガイドライン） |
| 76） | 日本泌尿器科学会編．前立腺肥大症診療ガイドライン．リッチヒルメディカル，2011（ガイドライン） |
| 77） | Rosen R, Altwein J, Boyle P, Kirby RS, Lukacs B, Meuleman E, O’Leary MP, Puppo P, Robertson C, Giuliano F. Lower urinary tract symptoms and male sexual dysfunction: the Multinational Survey of the Aging Male（MSAM-7）. Eur Urol 2003; 44: 637- 649（レベルIVa） |
| 78） | Basson R, Incrocci L, Rees P, Wang R, Morales AM, Schover L, Krychman M, Montejo AL, Sadovsky R. Sexual function in chronic illness and cancer. In: Montorsi F, Basson R, Adaikan G, Becher E, Clayton A, Giuliano F, Khoury S, Sharlip I eds. Sexual medicine: sexual dysfunctions in men and women. Edition 2010. Paris: Editions 21, 2010: 403- 495（ガイドライン） |
| 79） | McVary KT, McKenna KE. The relationship between erectile dysfunction and lower urinary tract symptoms: epidemiological, clinical, and basic science evidence. Curr Urol Rep 2004; 5: 251-257（総説） |
| 80） | Kawabe K, Ueno A, Takimoto Y, Aso Y, Kato H, YM617 Clinical Study Group. Use of an α1-blocker, YM617, in the treatment of benign prostatic hypertrophy. J Urol 1990; 144: 908- 912（レベルII） |
| 81） | Mann RD, Biswas P, Freemantle S, Pearce G, Wilton L. The pharmacovigilance of tamsulosin: event data on 12484 patients. BJU Int 2000; 85: 446- 450（レベルIVa） |
| 82） | Kawabe K, Yoshida M, Homma Y for the Silodosin Clinical Study Group. Silodosin, a new α1Aadrenoceptor- selective antagonist for treating benign prostatic hyperplasia: results of a phase III randomized, placebo-controlled, double-blind study in Japanese men. BJU Int 2006; 98: 1019-1024. （レベルII） |
| 83） | Andriole GL, Kirby R. Safety and tolerability of the dual 5α-reductase inhibitor dutasteride in the treatment of benign prostatic hyperplasia. Eur Urol 2003; 44: 82- 88（総説） |
| 84） | Traish AM, Hassani J, Guay AT, Zitzmann M, Hansen ML. Adverse side effects of 5α-reductase inhibitors therapy: persistent diminished libido and erectile dysfunction and depression in a subset of patients. J Sex Med 2011; 8: 872- 884（総説） |
| 85） | Tsukamoto T, Endo Y, Narita M. Efficacy and safety of dutasteride in Japanese men with benign prostatic hyperplasia. Int J Urol 2009; 16: 745- 750（レベルII） |
| 86） | McVary KT, Monnig W, Camps JL Jr, Young JM, Tseng L-J, van den Ende G. Sildenafil citrate improves erectile function and urinary symptoms in men with erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized, double-blind trial. J Urol 2007; 177: 1071-1077（レベルII） |
| 87） | McVary KT, Roehrborn CG, Kaminetsky JC, Auerbach SM, Wachs B, Young JM, Esler A, Sides GD, Denes BS. Tadalafil relieves lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol 2007; 177: 1401-1407（レベルIII） |
| 88） | Stief CG, Porst H, Neuser D, Beneke M, Ulbrich E. A randomized, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. Eur Urol 2008; 53: 1236-1244（レベルII） |
| 89） | American Urological Association Guideline: Management of Benign Prostatic Hyperplasia（BPH）. Revised, 2010. http://www.auanet.org/content/clinical-practice-guidelines/clinical-guidelines.cfm?sub= bph（ガイドライン） |
| 90） | Frieben RW, Lin H-C, Hinh PP, Berardinelli F, Canfield SE, Wang R. The impact of minimally invasive surgeries for the treatment of symptomatic benign prostatic hyperplasia on male sexual function: a systematic review. Asian J Androl 2010; 12: 500- 508（レベルI） |
| 91） | Arai Y, Aoki Y, Okubo K, Maeda H, Terada N, Matsuta Y, Maekawa S, Ogura K. Impact of interventional therapy for benign prostatic hyperplasia on quality of life and sexual function: a prospective study. J Urol 2000; 164: 1206-1211（レベルIVa） |
| 92） | 白石裕介，吉村耕治，井上貴博，大久保和俊，渡部淳，神波大己，兼松明弘，中村英二郎， 西山博之，賀本敏行，小川修．HoLEP 術後1 年目までの尿失禁・性機能の推移．泌尿紀要 2009; 55: 539- 543（レベルIVb） |
| 93） | Navaneethan SD, Vecchio M, Johnson DW, Saglimbene V, Graziano G, Pellegrini F, Lucisano G, Craig JC, Ruospo M, Gentile G, Manfreda VM, Querques M, Stroumza P, Torok M, Celia E, Gelfman R, Ferrari JN, Bednarek-Skublewska A, Dulawa J, Bonifati C, Hegbrant J, Wollheim C, Jannini EA, Strippoli GFM. Prevalence and correlates of self-reported sexual dysfunction in CKD: a meta-analysis of observational studies. Am J Kidney Dis 2010; 56: 670- 685（レベルI） |
| 94） | Naya Y, Soh J, Ochiai A, Mizutani Y, Ushijima S, Kamori K, Ukimura O, Kawauchi A, Fujito A, Ono T, Iwamoto N, Aoki T, Imada N, Marumo K, Murai M, Miki T. Significant decrease of the International Index of Erectile Function in male renal failure patients treated with hemodialysis. Int J Impot Res 2002; 14: 172-177（レベルIVb） |
| 95） | Kaufman JM, Hatzichristou DG, Mulhall JP, Fitch WP, Goldstein I. Impotence and chronic renal failure: a study of the hemodynamic pathophysiology. J Urol 1994; 151: 612- 618（レベルIVb） |
| 96） | Campese VM, Procci WR, Levitan D, Romoff MS, Goldstein DA, Massry SG. Autonomic nervous system dysfunction impotence in uremia. Am J Nephrol 1982; 2: 140-143（レベルIVb） |
| 97） | Nogués MA, Starkstein S, Dávalos M, Berthier M, Leiguarda R, García H. Cardiovascular reflexes and pudendal evoked responses in chronic haemodialysis patients. Funct Neurol 1991; 6: 359- 365 （レベルV） |
| 98） | Palmer BF. Sexual dysfunction in uremia. J Am Soc Nephrol 1999; 10: 1381-1388（総説） |
| 99） | 鈴木伸和，熊本悦明．男性透析患者の性機能の研究- 勃起障害の原因分析-．日泌尿会誌 1995; 86: 1098- 1107（レベルIVb） |
| 100） | Palmer BF. Sexual dysfunction in men and women with chronic kidney disease and end-stage kidney disease. Adv Ren Replace Ther 2003; 10: 48- 60（総説） |
| 101） | Schaefer RM, Kokot F, Wernze H, Geiger H, Heidland A. Improved sexual function in hemodialysis patients on recombinant erythropoietin: a possible role for prolactin. Clin Nephrol 1989; 31: 1-5. （レベルIVb） |
| 102） | Vallance P, Leone A, Calver A, Collier J, Moncada S. Accumulation of an endogeneous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992; 339: 572- 575（レベルIVb） |
| 103） | Procci WR. The study of sexual dysfunction in uremic males: problems for patients and investigators. Clin Exp Dial Apheresis 1983; 7: 289- 302（レベルIVb） |
| 104） | Procci WR, Goldstein DA, Adelstein J, Massry SG. Sexual dysfunction in the male patient with uremia: a reappraisal. Kidney Int 1981; 19: 317- 323（レベルIVb） |
| 105） | Shamsa A, Motavalli SM, Aghdam B. Erectile function in end-stage renal disease before and after renal transplantation. Transplant Proc 2005; 37: 3087- 3089（レベルIII） |
| 106） | Mirone V, Longo N, Fusco F, Verze P, Creta M, Parazzini F, Imbimbo C. Renal transplantation does not improve erectile function in hemodialysed patients. Eur Urol 2009; 56: 1047-1053（レベルIII） |
| 107） | Hirshkowitz M, Karacan I, Arcasoy MO, Acik G, Narter EM, Williams RL. Prevalence of sleep apnea in men with erectile dysfunction. Urology 1990; 36: 232- 234（レベルIVb） |
| 108） | Budweiser S, Enderlein S, Jörres RA, Hitzl AP, Wieland WF, Pfeifer M, Arzt M. Sleep apnea is an independent correlate of erectile and sexual dysfunction. J Sex Med 2009; 6: 3147-3157（レベルIVb） |
| 109） | Guilleminault C, Eldridge FL, Tilkian A, Simmons FB, Dement WC. Sleep apnea syndrome due to upper airway obstruction: a review of 25 cases. Arch Intern Med 1977; 137: 296- 300（レベルV） |
| 110） | Seftel AD, Strohl KP, Loye TL, Bayard D, Kress J, Netzer NC. Erectile dysfunction and symptoms of sleep disorders. Sleep 2002; 25: 643- 647（レベルIVb） |
| 111） | Yamagishi K, Ohira T, Nakano H, Bielinski SJ, Sakurai S, Imano H, Kiyama M, Kitamura A, Sato S, Konishi M, Shahar E, Folsom AR, Iso H, Tanigawa T. Cross-cultural comparison of the sleep-disordered breathing prevalence among Americans and Japanese. Eur Respir J 2010; 36: 379-384（レベルIVb） |
| 112） | Gonçalves MA, Guilleminault C, Ramos E, Palha A, Paiva T. Erectile dysfunction, obstructive sleep apnea syndrome and nasal CPAP treatment. Sleep Med 2005; 6: 333- 339（レベルV） |
| 113） | Taskin U, Yigit O, Acioglu E, Aricigil M, Toktas G, Guzelhan Y. Erectile dysfunction in severe sleep apnea patients and response to CPAP. Int J Impot Res 2010; 22: 134-139（レベルIVb） |
| 114） | Margel D, Tal R, Livne PM, Pillar G. Predictors of erectile function improvement in obstructive sleep apnea patients with long-term CPAP treatment. Int J Impot Res 2005; 17: 186-190（レベルIVb） |
| 115） | Perimenis P, Konstantinopoulos A, Karkoulias K, Markou S, Perimeni P, Spyropoulos K. Sildenafil combined with continuous positive airway pressure for treatment of erectile dysfunction in men with obstructive sleep apnea. Int Urol Nephrol 2007; 39: 547- 552（レベルII） |
| 116） | Roizenblatt S, Guilleminault C, Poyares D, Cintra F, Kauati A, Tufik S. A double-blind, placebo-controlled, crossover study of sildenafil in obstructive sleep apnea. Arch Intern Med 2006; 166: 1763- 1767（レベルII） |
| 117） | Kiroglu AF, Bayrakli H, Yuca K, Cankaya H, Kiris M. Nasal obstruction as a common side-effect of sildenafil citrate. Tohoku J Exp Med 2006; 208: 251-254（レベルV） |
| 118） | Lue TF. Neurogenic erectile dysfunction. Clin Auton Res 2001; 11: 285- 294（総説） |
| 119） | Rees PM, Fowler CJ, Maas CP. Sexual function in men and women with neurological disorders. Lancet 2007; 369: 512- 525（総説） |
| 120） | Sakakibara R, Uchiyama T, Yamanishi T, Kishi M. Genitourinary dysfunction in Parkinson’s disease. Mov Disord 2010; 25: 2-12（総説） |
| 121） | Biering-Sørensen F, Sønksen J. Penile erection in men with spinal cord or cauda equina lesions. Semin Neurol 1992; 12: 98-105（総説） |
| 122） | Zorzon M, Zivadinov R, Bosco A, Bragadin LM, Moretti R, Bonfigli L, Morassi P, Iona LG, Cazzato G. Sexual dysfunction in multiple sclerosis: a case-control study. I. Frequency and comparison of groups. Mult Scler 1999; 5: 418- 427（レベルIVb） |
| 123） | Bener A, Al-Hamaq AOAA, Kamran S, Al-Ansari A. Prevalence of erectile dysfunction in male stroke pa tients, and associated co-morbidities and risk factors. Int Urol Nephrol 2008; 40: 701-708（レベルV） |
| 124） | Nikoobakht M, Motamedi M, Orandi A, Meysamie A, Emamzadeh A. Sexual dysfunction in epileptic men. Urol J 2007; 4: 111-117（レベルV） |
| 125） | Bronner G, Royter V, Korczyn AD, Giladi N. Sexual dysfunction in Parkinson’s disease. J Sex Marital Ther 2004; 30: 95-105（レベルV） |
| 126） | Papatsoris AG, Deliveliotis C, Singer C, Papapetropoulos S. Erectile dysfunction in Parkinson’s disease. Urology 2006; 67: 447- 451（総説） |
| 127） | Beck RO, Betts CD, Fowler CJ. Genitourinary dysfunction in multiple system atrophy: clinical features and treatment in 62 cases. J Urol 1994; 151: 1336-1341（レベルV） |
| 128） | Kirchhof K, Apostolidis AN, Mathias CJ, Fowler CJ. Erectile and urinary dysfunction may be the presenting features in patients with multiple system atrophy: a retrospective study. Int J Impot Res 2003; 15: 293- 298（レベルV） |
| 129） | Smaldone M, Sukkarieh T, Reda A, Khan A. Epilepsy and erectile dysfunction: a review. Seizure 2004; 13: 453- 459（総説） |
| 130） | Brown RG, MacCarthy B, Gotham A-M, Der GJ, Marsden CD. Depression and disability in Parkinson’s disease: a follow-up of 132 cases. Psychol Med 1988; 18: 49- 55（レベルV） |
| 131） | Saleh RA, Ranga GM, Raina R, Nelson DR, Agarwal A. Sexual dysfunction in men undergoing infertility evaluation: a cohort observational study. Fertil Steril 2003; 79: 909-912（レベルIVa） |
| 132） | Monga M, Alexandrescu B, Katz SE, Stein M, Ganiats T. Impact of infertility on quality of life, marital adjustment, and sexual function. Urology 2004; 63: 126-130（レベルIVb） |
| 133） | O’Brien JH, Lazarou S, Deane L, Jarvi K, Zini A. Erectile dysfunction and andropause symptoms in infertile men. J Urol 2005; 174: 1932-1934（レベルIVb） |
| 134） | Slag MF, Morley JE, Elson MK, Trence DL, Nelson CJ, Nelson AE, Kinlaw WB, Beyer HS, Nuttall FQ, Shafer RB. Impotence in medical clinic outpatients. JAMA 1983; 249: 1736-1740（レベルIVb） |
| 135） | Montorsi F, Basson R, Adaikan G, Becher E, Clayton A, Giuliano F, Khoury S, Sharlip I eds. Sexual medicine: sexual dysfunctions in men and women. Edition 2010. Paris: Editions 21, 2010（ガイドライン） |
| 136） | Finger WW, Lund M, Slagle MA. Medications that may contribute to sexual disorders. A guide to assessment and treatment in family practice. J Fam Pract 1997; 44: 33-43（総説） |
| 137） | Hsieh J-T, Lue TF, Mueller SC, Aboseif SR, Orvis BR, Tanagho EA. The influence of blood flow and blood pressure on penile erection. Int J Impot Res 1989; 1: 35-42（総説） |
| 138） | Doumas M, Tsakiris A, Douma S, Grigorakis A, Papadopoulos A, Hounta A, Tsiodras S, Dimitriou D, Giamarellou H. Factors affecting the increased prevalence of erectile dysfunction in Greek hypertensive compared with normotensive subjects. J Androl 2006; 27: 469-477（レベルIVb） |
| 139） | Llisterri JL, Lozano Vidal JV, Aznar Vicente J, Argaya Roca M, Pol Bravo C, Sanchez Zamorano MA, Ferrario CM. Sexual dysfunction in hypertensive patients treated with losartan. Am J Med Sci 2001; 321: 336-341（レベルIII） |
| 140） | Della Chiesa A, Pfiffner D, Meier B, Hess OM. Sexual activity in hypertensive men. J Hum Hypertens 2003; 17: 515-521（レベルIII） |
| 141） | Ekman E, Hägg S, Sundström A, Werkström V. Antihypertensive drugs and erectile dysfunction as seen in spontaneous reports, with focus on angiotensin II type I receptor blockers. Drug Healthc Patient Saf 2010; 2: 21-25（レベルIVb） |
| 142） | Potosky AL. Comparing health care systems: the importance and limitations of outcome measures. Med Care 2002; 40: 359-361（レベルV） |
| 143） | Hoffman RM, Hunt WC, Gilliland FD, Stephenson RA, Potosky AL. Patient satisfaction with treatment decisions for clinically localized prostate carcinoma. Results from the Prostate Cancer Outcomes Study. Cancer 2003; 97: 1653-1662（レベルIII） |
| 144） | Shiri R, Koskimäki J, Häkkinen J, Tammela TLJ, Auvinen A, Hakama M. Effect of nonsteroidal anti-inflammatory drug use on the incidence of erectile dysfunction. J Urol 2006; 175: 1812-1816（レベルIVb） |
| 145） | Gleason JM, Slezak JM, Jung H, Reynolds K, Van Den Eeden SK, Haque R, Quinn VP, Loo RK, Jacobsen SJ. Regular nonsteroidal anti-inflammatory drug use and erectile dysfunction. J Urol 2011; 185: 1388-1393（レベルIVa） |
| 146） | Rosen RC. Understanding different types of problems in men and women. Round Table 9, Drug-induced sexual dysfunction. Joint Congress of the European and International Societies for Sexual Medicine, 2008. http://www.issmessm2008.info/（レベルVI） |
